BCAX
Bicara Therapeutics Inc. Common Stock$17.94-0.88 (-4.68%)Prev Close$18.79·MCap$1.07B·P/E3.57·Vol230.0K·Yield—
▲
Buys (12M)
1
$4.80M
▼
Sells (12M)
27
$7.57M
◆
Net Activity
Net Seller
$2.77M
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at Bicara Therapeutics Inc. Common Stock (BCAX) has been mixed between buying and selling, with 1 insider purchase totaling $4.80M and 27 insider sales totaling $7.57M. The most recent insider transaction was by Mazumdar Claire (director, officer: Chief Executive Officer), who sold $282.4K worth of shares on Mar 20, 2026. Bicara Therapeutics Inc. Common Stock operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.07B.
BCAX Insider Trading Activity
BCAX Insider Buying Activity
The following table shows recent insider purchases of Bicara Therapeutics Inc. Common Stock (BCAX) stock reported via SEC Form 4 filings.
BCAX Insider Selling Activity
The following table shows recent insider sales of Bicara Therapeutics Inc. Common Stock (BCAX) stock reported via SEC Form 4 filings.